window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : January 31, 2026

  • News
  • About Us
Contact Us

Medical devices

  • Infectious Diseases,Market Access & Commercialization,Medical devices

    Biocomposites launches SYNICEM spacers in Canada for joint revision surgery

    Biocomposites has launched its SYNICEM antibiotic-loaded preformed spacers in Canada, [...]

    January 30, 2026
  • Diagnostics,Infectious Diseases,Medical devices,Technology and platforms

    En Carta Diagnostics receives FDA breakthrough device designation for Lyme disease test

    En Carta Diagnostics has received FDA Breakthrough Device Designation for [...]

    January 30, 2026
  • Drug Delivery & Formulation,Healthcare leadership,Market Access & Commercialization,Medical devices,Movers & Shakers

    ViCentra appoints Reman McDonagh as vice president, global marketing to support Kaleido scale-up

    ViCentra has appointed Reman McDonagh as vice president, global marketing [...]

    January 29, 2026
  • Digital Health,Healthcare leadership,Medical devices,Mental health,Regulatory Affairs

    Mental health systems strain as demand and funding shifts drive push for multimodal care

    Mental health systems in the US and UK have entered [...]

    January 29, 2026
  • Biologics & Biosimilars,Drug Delivery & Formulation,Medical devices,Patient Centricity,Pharmaceuticals and therapeutics

    Datwyler, LTS Device Technologies, and Stevanato Group collaborate on large-volume self-administration solutions

    Datwyler, LTS Device Technologies, and Stevanato Group have launched a [...]

    January 20, 2026
  • Central Nervous System,Digital Health,Medical devices,Patient Centricity,Pharmaceuticals and therapeutics

    NeuroVice seizure oral injury device now available through BlinkRx

    The PATI device from NeuroVice, designed to protect against oral [...]

    January 20, 2026
  • Artificial Intelligence,Digital Health,Healthcare leadership,Medical devices,Pharmaceuticals and therapeutics,Research & Development,Technology and platforms

    From awareness to action: Linus Health drives next era of early brain health detection

    Linus Health is accelerating its efforts in early brain health [...]

    January 19, 2026
  • CDMOs & Manufacturing,Drug Delivery & Formulation,Medical devices,Pharmaceuticals and therapeutics,Technology and platforms

    MGS launches A.i.r. platform delivering customizable auto-injector solutions

    MGS has launched the A.i.r. Platform, a new customizable auto-injector [...]

    January 19, 2026
  • Digital Health,Market Access & Commercialization,Medical devices,Research & Development,Technology and platforms

    Profusa launches Lumee tissue oxygen research offering to generate first commercial revenue

    Profusa has launched a research-use-only version of its Lumee tissue [...]

    January 19, 2026
  • Biomanufacturing,Drug Development,Medical devices,Pharmaceuticals and therapeutics,Technology and platforms

    Thermo Fisher launches DXR3 SmartRaman+ for at-line pharmaceutical and industrial testing

    Thermo Fisher Scientific has launched the DXR3 SmartRaman+ Raman Spectrometer [...]

    January 14, 2026
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Evestia Clinical acquires ICRC-Weyer to expand full-service clinical research in Europe
    Categories: Biotech, CDMOs & Manufacturing, Clinical Development, Clinical Trials, Partnerships & Funding
  • Mental health systems strain as demand and funding shifts drive push for multimodal care
    Categories: Digital Health, Healthcare leadership, Medical devices, Mental health, Regulatory Affairs
  • Nine-gene signature linked to lapatinib resistance in HER2-positive breast cancer
    Categories: Clinical studies, Drug Development, Oncology, Precision medicine, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top